Employment Links

H. Con. Res. 39 — Rep. Karen Bass: A bill to remove administrative barriers to participation of Indian tribes in federal child welfare programs, and increase federal funding for tribal child welfare programs; Rep. Jackie Speier: A concurrent resolution expressing the sense of Congress that Title IX of the Education Amendments of 1972 applies to the National Collegiate Athletics Association (NCAA), and the National Collegiate Athletics Association (NCAA) should work to prevent discrimination on the basis of sex in its programs and activities; Rep. Brad Wenstrup: — A bill to improve the employer-provided child care tax credit; Rep. Julia Brownley: A bill to increase the frequency that the Advisory Committee on Women Veterans shall submit a report to the secretary of Veterans Affairs; Rep. Ann Kuster: — A bill to reauthorize grants for the Rape, Abuse and Incest National Network. more »

Some Bills Introduced: A bill to ensure the safety of cosmetics; banning the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics; expanding the membership of the Advisory Committee on Minority Veterans to include veterans who are lesbian, gay, bisexual, transgender, gender diverse, gender non-conforming, intersex, or queer; mammography screening for veterans who served in locations associated with toxic exposure; providing coverage for custom fabricated breast prostheses following a mastectomy; A bill to improve social security benefits for widows and widowers in two-income households   Weekly Legislative Update June 21, 2021  … more »

Results from a Phase 3 clinical trial enrolling 29,960 adult volunteers in the United States and Mexico show that the investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease. The candidate showed 100% protection against moderate and severe disease. In people at high risk of developing complications from COVID-19 (people 65 years or older and people under age 65 with certain comorbidities or with likely regular exposure to COVID-19), the vaccine showed 91.0% efficacy in preventing symptomatic COVID-19 disease. more »

"The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S.— and now we’re about to find out. After a nearly 20-year dry spell in new treatments for Alzheimer’s disease, the Food and Drug Administration (FDA) just approved a new Alzheimer’s medication, Aduhelm (aducanumab), developed by Biogen, with an expected annual price tag of $56,000. While the scientific community debates the evidence of the effectiveness of this new drug, the FDA’s decision raises hope for Alzheimer’s patients and their families, along with serious cost concerns for patients and payers, particularly Medicare." more »